Usefulness of High Resolution T2-Weighted Images in the Evaluation and Surveillance of Vestibular Schwannomas? Is Gadolinium Needed?


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 4 12 2019
medline: 25 8 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

First aim of study was to compare the diagnostic accuracy of high resolution T2-WI (HRT2-WI) and gadolinium-enhanced T1-weighted image (Gd T1-WI) sequences in quantitative evaluation of vestibular schwannomas (VS). The second one was to determine through qualitative evaluation when Gd-injection should be recommended. Two observers in consensus retrospectively reviewed 137 magnetic resonance imaging (MRI) scans of patients with histological diagnosis of VS (33 women, 26 men), 116 with both HRT2-WI and Gd T1-WI. The examinations were subdivided in: surveillance (10), pretreatment (30), posttreatment (43), and posttreatment follow-up (33) studies. Quantitative evaluation was based on size measurement of the lesion. Structural details of the lesion, facial nerve course, and involvement of the fundus of the internal auditory canal were assessed for the qualitative evaluation in both sequences. No statistically significant changes were demonstrated between size measurement in the HRT2-WI and Gd T1-WI (p = 0.329). Sensitivity, specificity, and accuracy of HRT2-WI in the detection of lesional size were 90.4, 98.9, 92.5%, respectively. HRT2-WI was worse for characterization of structural details in pretreatment, posttreatment, and posttreatment follow-up examinations. HRT2-WI showed better or equal capability for all the groups in the demonstration of the facial nerve course. In the evaluation of the involvement of the fundus of the internal auditory canal, HRT2-WI showed worse results or had a complementary role for the posttreatment and posttreatment follow-up groups, while in the other groups was considered mainly equal or complementary. Only in the surveillance group, HRT2-WI was never worse for all the criteria. Results for quantitative evaluation were similar in both the sequences. Gadolinium injection can be avoided only in surveillance studies.

Identifiants

pubmed: 31789801
doi: 10.1097/MAO.0000000000002436
pii: 00129492-202001000-00029
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e103-e110

Références

Propp JM, McCarthy BJ, Davis FG, et al. Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 2006; 8:1–11.
Lin D, Hegarty JL, Fischbein NJ, et al. The prevalence of “incidental” acoustic neuroma. Arch Otolaryngol Head Neck Surg 2005; 131:241–244.
Babu R, Sharma R, Bagley JH, et al. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 2013; 119:121–130.
Younes E, Montava M, Bachelard-Serra M, et al. Intracanalicular vestibular schwannomas: initial clinical manifestation, imaging classification, and risk stratification for management proposal. Otol Neurotol 2017; 38:1345–1350.
Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol 2017; 38:2034–2043.
Zou J, Hirvonen T. “Wait and scan” management of patients with vestibular schwannoma and the relevance of non-contrast MRI in the follow-up. J Otol 2017; 12:174–184.
Jian BJ, Kaur G, Sayegh ET, et al. Fractionated radiation therapy for vestibular schwannoma. J Clin Neurosci 2014; 21:1083–1088.
Coelho DH, Tang Y, Suddarth B, et al. MRI surveillance of vestibular schwannomas without contrast enhancement: clinical and economic evaluation. Laryngoscope 2018; 128:202–209.
Abele TA, Besachio DA, Quigley EP, et al. Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions. AJNR Am J Neuroradiol 2014; 35:2366–2370.
Bayraktaroglu S, Pabuccu E, Ceylan N, et al. Evaluation of the necessity of contrast in the follow-up MRI of schwannomas. Diagn Interv Radiol 2011; 17:209–215.
Ryan M, Weissman JL, Kaylie D. Is Gadolinium contrast enhancement necessary in screening MRI for asymmetric sensorineural hearing loss? Laryngoscope 2015; 125:783–784.
Ozgen B, Oguz B, Dolgun A. Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas. AJNR Am J Neuroradiol 2009; 30:985–991.
McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275:772–782.
Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals 2016; 29:365–376.
Kocaoglu M, Bulakbasi N, Ucoz T, et al. Comparison of contrast-enhanced T1-weighted and 3D constructive interference in steady state images for predicting outcome after hearing-preservation surgery for vestibular schwannoma. Neuroradiology 2003; 45:476–481.
Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular, schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995; 113:179–180.
Fortnum H, O’Neill C, Taylor R, et al. The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history. Health Technol Assess 2009; 13:iii–iv. ix–xi, 1–154.
Kanzaki J, Tos M, Sanna M, et al. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003; 24:642–648. discussion 648-9.
Schmalbrock P, Chakeres DW, Monroe JW, et al. Assessment of internal auditory canal tumors: a comparison of contrast-enhanced T1-weighted and steady-state T2-weighted gradient-echo MR imaging. AJNR Am J Neuroradiol 1999; 20:1207–1213.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174.
Sartoretti-Schefer S, Kollias S, Valavanis A. Spatial relationship between vestibular schwannoma and facial nerve on three-dimensional T2-weighted fast spin-echo MR images. AJNR Am J Neuroradiol 2000; 21:810–816.
Kernohan MD, Blackmore KJ, Johnson IJ, et al. Magnetic resonance imaging: is a single scan ever enough for the diagnosis of acoustic neuroma? J Laryngol Otol 2006; 120:1061–1063.
Maeta M, Saito R, Nameki H. False-positive magnetic resonance image in the diagnosis of small acoustic neuroma. J Laryngol Otol 2001; 115:842–844.
Benech F, Perez R, Fontanella MM, et al. Cystic versus solid vestibular schwannomas: a series of 80 grade III-IV patients. Neurosurg Rev 2005; 28:209–213.
Piccirillo E, Wiet MR, Flanagan S, et al. Cystic vestibular schwannoma: classification, management, and facial nerve outcomes. Otol Neurotol 2009; 30:826–834.
Kim DY, Lee JH, Goh MJ, et al. Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma. AJNR Am J Neuroradiol 2014; 35:1825–1829.
Crowson MG, Rocke DJ, Hoang JK, et al. Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss. Neuroradiology 2017; 59:727–736.
Park CK, Kim DC, Park SH, et al. Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas. J Neurosurg 2006; 105:576–580.
Nicolli EA, Ruckenstein M. What is the risk of malignant transformation of vestibular schwannoma following radiosurgery? Laryngoscope 2015; 125:1761–1762.

Auteurs

Francesca B Pizzini (FB)

Neuroradiology, Department of Diagnostics and Pathology.

Alessandro Sarno (A)

Radiology, University of Verona, "Hospital G.B. Rossi".

Ilaria Boscolo Galazzo (IB)

Department of Computer Science.

Francesco Fiorino (F)

Otolaryngology, "Mater Salutis" Hospital, Legnago (Verona).

Anna M R Aragno (AMR)

Otolaryngology, University of Verona.

Elisa Ciceri (E)

Neuroradiology, Department of Diagnostics and Pathology.

Claudio Ghimenton (C)

Pathology, Department of Diagnostics and Pathology, Verona University Hospital, Verona, Italy.

Giancarlo Mansueto (G)

Radiology, University of Verona, "Hospital G.B. Rossi".

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH